期刊文献+

戊型肝炎患者血清GP73变化特征及意义

Characteristics of serum GP73 for patients with hepatitis E and its clinical significances
原文传递
导出
摘要 目的观察戊型肝炎患者血清GP73变化特征。方法分析80例健康体检者(对照组)和66例戊型肝炎患者(观察组)血清GP73水平的变化。结果对照组研究对象血清GP73水平为(38.82±15.67)ng/ml,观察组患者血清GP73为(80.06±52.33)ng/ml,较对照组显著升高,差异具有统计学意义(t=6.785、P<0.001);患者血清GP73水平与丙氨酸氨基转移酶(ALT)活性(r=0.28、P=0.015)、天门冬氨酸氨基转移酶(AST)活性(r=0.36、P=0.002)总胆红素(TBil)水平(r=0.47、P<0.001)均呈正相关,而与凝血酶原活动度(PTA)水平呈负相关(r=-0.329、P=0.004)。结论血清GP73显著升高的人群需考虑急性戊型肝炎病毒感染的可能。戊型肝炎患者的血清GP73水平可能与肝功能损伤程度具有一定的相关性。 Objective To investigate the variable characteristics of serum GP73 for patients with hepatitis E. Methods The changes of GP73 level in serum of 80 healthy subjects(control group) and 66 patients with hepatitis E were detected by quantitative enzyme-linked immunosorbent assay. Results The median level of serum GP73 for patients with hepatitis E(80.06 ± 52.33 ng/ml) was significantly increased than that of 80 healthy control subjects(38.82 ± 15.67 ng/ml), with significant difference(t = 6.785, P〈0.0001). The level of serum GP73 in patients with hepatitis E had positive correlation with the serum activity of alanine aminotransferase(ALT)(r = 0.28, P = 0.015), aspartate aminotransferase(AST)(r = 0.36, P = 0.002) and the level of serum total bilirubin(TBil)(r = 0.47, P〈0.001). While it had negative correlation with the prothrombin time activity(PTA)(r =-0.329, P = 0.004). Conclusions The possibility of acute hepatitis E infection should be considered for those who with significangly elevated serum GP73. Serum GP73 levels in patients with hepatitis E may be correlated with liver damage.
作者 蒋煜 徐飞 胡居龙 华文浩 李坪 魏红山 Jiang Yu;Fei Xu;Hu Julong;Hua Wenhao;Li Ping;Wei Hongshan(Department of Gastroenterology;Clinical Lab,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China)
出处 《中华实验和临床感染病杂志(电子版)》 CAS 2018年第2期179-182,共4页 Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
基金 国家自然科学基金(No.81271901) 北京市自然科学基金(No.7152073) 首都特色临床研究(No.Z141107002514132) 首都医学发展科研基金(No.2014-2-2171)
关键词 肝炎 戊型 高尔基体糖蛋白73 肝功能损伤 诊断 Hepatitis E Golgi protein 73 Liver injury Diagnosis
  • 相关文献

参考文献3

二级参考文献28

  • 1Riener MO, Stenner F, Liewen H, et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 2009, 49: 1602-1609.
  • 2MaoY, YangH, Xu H, et al. Golgi protein 73 (GOLPH2) isa valuable serum marker for hepatocellular carcinoma. Gut,2010, 59 : 1687-1693.
  • 3Wei H, Li B, Zhang R, et al. Serum GP73, a marker for evaluating progression in patients with chronic HBV infections. PLoS One, 2013,8 :e53862.
  • 4Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology ,2002,123 : 1705-1725.
  • 5Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981,1:431-435.
  • 6中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝肝病诊疗指南(2010年修订版).中华肝脏病杂志,2010,18:163-166.
  • 7Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 2012, 55:2005-2023.
  • 8Zeng MD, Li YM, Chen CW, et al. Guidelines for the diagnosis and treatment of alcoholic liver disease. J Dig Dis, 2008,9 : 113- 116.
  • 9Liu X, Wan X, Li Z, et al. Golgi protein 73 ( GP73), a useful serum marker in liver diseases. Clin Chem Lab Med,2011 ,49: 1311-1316.
  • 10Kladney RD,Bulla GA,Guo L,et al.GP73,a novel Golgi-localized protein upregulated by viral infection.Gene,2000,249:53-65.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部